Moderna (MRNA) Tax Rate Growth (3y) (2021 - 2026)

Moderna (MRNA) Tax Rate Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Moderna 22.07 Bn 16.87 Bn -566.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12,658.00
Dec 31, 2025 -1,486.00
Sep 30, 2025 -2,125.00
Jun 30, 2025 -1,205.00
Mar 31, 2025 -1,425.00
Dec 31, 2024 -461.00
Sep 30, 2024 3,193.00
Mar 31, 2024 -395.00
Dec 31, 2023 -20,926.00
Sep 30, 2023 -8,496.00
Dec 31, 2022 1,110.00
Sep 30, 2022 1,415.00
Jun 30, 2022 1,096.00
Mar 31, 2022 1,351.00
Dec 31, 2021 1,014.00
Jun 30, 2021 941.00